blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1239876

EP1239876 - HCV VACCINE COMPOSITIONS [Right-click to bookmark this link]
Former [2002/38]VACCINE COMPOSITIONS
[2007/35]
StatusNo opposition filed within time limit
Status updated on  05.06.2009
Database last updated on 13.11.2024
Most recent event   Tooltip22.10.2010Lapse of the patent in a contracting state
New state(s): GR		published on 24.11.2010  [2010/47]
Applicant(s)For all designated states
CSL Limited
45 Poplar Road
Parkville, VIC 3052 / AU
For all designated states
Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street
Emeryville, CA 94608 / US
[2008/31]
Former [2007/04]For all designated states
CSL LIMITED
45 Poplar Road
Parkville, VIC 3052 / AU
For all designated states
Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street
Emeryville, CA 94608 / US
Former [2002/38]For all designated states
CSL LIMITED
45 Poplar Road
Parkville, VIC 3052 / AU
For all designated states
CHIRON CORPORATION
4560 Horton Street
Emeryville California 94608-2916 / US
Inventor(s)01 / DRANE, Debbie
72 Mulcahy Road
Bullengarook, VIC 3437 / AU
02 / COX, John
140 Dunns Road
Bullengarook, VIC 3437 / AU
03 / HOUGHTON, Michael, Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street - R440
Emeryville, CA 94608 / US
04 / PALIARD, Xavier, Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street - R440
Emeryville, CA 94608 / US
 [2007/45]
Former [2002/38]01 / DRANE, Debbie
72 Mulcahy Road
Bullengarook, VIC 3437 / AU
02 / COX, John
140 Dunns Road
Bullengarook, VIC 3437 / AU
03 / HOUGHTON, Michael, Chiron Corporation
4560 Horton Street - R440
Emeryville, CA 94608 / US
04 / PALIARD, Xavier, Chiron Corporation
4560 Horton Street - R440
Emeryville, CA 94608 / US
Representative(s)Duckworth, Timothy John, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2002/38]Duckworth, Timothy John, et al
J.A. Kemp & Co., 14 South Square, Gray's Inn
London WC1R 5JJ / GB
Application number, filing date00975681.817.11.2000
[2002/38]
WO2000AU01410
Priority number, dateUS19990166652P19.11.1999         Original published format: US 166652 P
US20000224362P11.08.2000         Original published format: US 224362 P
[2002/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0137869
Date:31.05.2001
Language:EN
[2001/22]
Type: A1 Application with search report 
No.:EP1239876
Date:18.09.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 31.05.2001 takes the place of the publication of the European patent application.
[2002/38]
Type: B1 Patent specification 
No.:EP1239876
Date:30.07.2008
Language:EN
[2008/31]
Search report(s)International search report - published on:AU31.05.2001
(Supplementary) European search report - dispatched on:EP19.03.2003
ClassificationIPC:A61K39/385, A61K39/29, A61P31/12
[2002/38]
CPC:
A61K39/29 (EP,US); A61K39/385 (KR); A61K39/12 (EP,US);
A61P31/12 (EP); A61P37/02 (EP); A61K2039/55544 (EP,US);
A61K2039/55566 (EP,US); A61K2039/55572 (EP,US); A61K2039/55577 (EP,US);
A61K2039/57 (EP,US); C12N2770/24234 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:HCV-IMPFSTOFF ZUSAMMENSETZUNGEN[2007/35]
English:HCV VACCINE COMPOSITIONS[2007/35]
French:COMPOSITIONS VACCINALES HCV[2007/44]
Former [2002/38]IMPFSTOFF ZUSAMMENSETZUNGEN
Former [2002/38]VACCINE COMPOSITIONS
Former [2002/38]COMPOSITIONS VACCINALES
Entry into regional phase27.05.2002National basic fee paid 
27.05.2002Search fee paid 
27.05.2002Designation fee(s) paid 
27.05.2002Examination fee paid 
Examination procedure17.05.2001Request for preliminary examination filed
International Preliminary Examining Authority: AU
27.05.2002Amendment by applicant (claims and/or description)
27.05.2002Examination requested  [2002/38]
03.05.2004Despatch of a communication from the examining division (Time limit: M04)
03.09.2004Reply to a communication from the examining division
11.08.2005Despatch of a communication from the examining division (Time limit: M06)
21.02.2006Reply to a communication from the examining division
20.11.2006Despatch of a communication from the examining division (Time limit: M02)
20.12.2006Reply to a communication from the examining division
09.08.2007Despatch of a communication from the examining division (Time limit: M02)
07.09.2007Reply to a communication from the examining division
15.10.2007Communication of intention to grant the patent
31.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
18.04.2008Fee for grant paid
18.04.2008Fee for publishing/printing paid
Opposition(s)06.05.2009No opposition filed within time limit [2009/28]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
18.04.2008Request for further processing filed
18.04.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
27.05.2002Renewal fee patent year 03
12.11.2003Renewal fee patent year 04
12.11.2004Renewal fee patent year 05
14.11.2005Renewal fee patent year 06
14.11.2006Renewal fee patent year 07
15.11.2007Renewal fee patent year 08
31.03.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT30.07.2008
CY30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
TR30.07.2008
GR31.10.2008
IE17.11.2008
LU17.11.2008
MC30.11.2008
PT30.12.2008
[2010/47]
Former [2010/37]AT30.07.2008
CY30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
TR30.07.2008
IE17.11.2008
LU17.11.2008
MC30.11.2008
PT30.12.2008
Former [2010/34]AT30.07.2008
CY30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
IE17.11.2008
LU17.11.2008
MC30.11.2008
PT30.12.2008
Former [2010/32]AT30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
IE17.11.2008
LU17.11.2008
MC30.11.2008
PT30.12.2008
Former [2009/47]AT30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
IE17.11.2008
MC30.11.2008
PT30.12.2008
Former [2009/29]AT30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
MC30.11.2008
PT30.12.2008
Former [2009/20]AT30.07.2008
DK30.07.2008
FI30.07.2008
NL30.07.2008
PT30.12.2008
Former [2009/15]AT30.07.2008
FI30.07.2008
NL30.07.2008
PT30.12.2008
Former [2009/12]FI30.07.2008
NL30.07.2008
PT30.12.2008
Documents cited:Search[YA]WO9001947  (LIPOSOME CO INC [US]) [Y] 12,13,15 * page 6 - page 7 * * page 10, line 33 - line 36 * * page 11, line 12 - line 16 * * page 12, line 9 - line 11 * * the whole document * [A] 1-25;
 [X]WO9604385  (INNOGENETICS NV [BE], et al) [X] 10 * page 26, line 24 *;
 [XY]WO9701640  (SMITHKLINE BEECHAM BIOLOG [BE], et al) [X] 1-9,11,14,16-25 * abstract * * examples 1,2 * * page 5, line 20 - line 31 * * page 1, line 24 - line 30 * * page 1, line 10 - line 14 * * page 5, line 28 - line 31 * [Y] 12,13,15;
 [PX]WO0048630  (CSL LTD [AU], et al) [PX] 1-25 * abstract * * page 19, line 23 *;
 [A]  - HITOMI Y ET AL, "High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.", VIRAL IMMUNOLOGY, (1995), vol. 8, no. 2, ISSN 0882-8245, pages 109 - 119, XP000978724 [A] 1-25 * the whole document *
 [A]  - LEE JAE WOO ET AL, "Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies.", JOURNAL OF VIROLOGY, (199901), vol. 73, no. 1, ISSN 0022-538X, pages 11 - 18, XP002124766 [A] 1-25 * the whole document *
 [A]  - LAMONACA VINCENZO ET AL, "Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development.", HEPATOLOGY, (199910), vol. 30, no. 4, ISSN 0270-9139, pages 1088 - 1098, XP001027157 [A] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1002/hep.510300435
 [A]  - KHEMKA VIMLA ET AL, "The capacity of a combined liposomal hepatitis B and C vaccine to stimulate humoral and cellular responses in mice.", VIRAL IMMUNOLOGY, (1998), vol. 11, no. 2, ISSN 0882-8245, pages 73 - 78, XP009006302 [A] 1-25 * the whole document *
 [T]  - POLAKOS N K ET AL, "Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 1 MAR 2001, (20010301), vol. 166, no. 5, ISSN 0022-1767, pages 3589 - 3598, XP001146112 [T] 1-25 * the whole document *
International search[X]AU686891B  (ISCOTEC AB);
 [X]AU1145699  (SMITHKLINE BEECHAM BIOLOGICALS SA);
 [X]AU9623898  (SMITHKLINE BEECHAM BIOLOGICALS SA);
 [X]AU714930B  (SMITHKLINE BEECHAM BIOLOG);
 [XP]AU5509999  (SMITHKLINE BEECHAM BIOLOG);
 [XP]AU2651500  (CSL LTD);
 [Y]  - NAKANISHI T. ET AL., "Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1997), vol. 240, pages 793 - 797, XP002908766

DOI:   http://dx.doi.org/10.1006/bbrc.1997.7749
 [Y]  - MOREIN B. AND BENGTSSON K.L., "Functional aspects of iscoms", IMMUNOLOGY AND CELL BIOLOGY, (1998), vol. 76, pages 295 - 299, XP009006245

DOI:   http://dx.doi.org/10.1046/j.1440-1711.1998.00756.x
 [Y]  - SELBY M.J. ET AL., "Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome", JOURNAL OF GENERAL VIROLOGY, (1993), vol. 74, pages 1103 - 1113, XP002918678
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.